'Emerging' Biomarker May Predict MCI Years Before Symptoms

Measuring levels of synaptic protein NPTX2 in cognitively normal adults may help predict onset of mild cognitive impairment years before symptoms emerge.
Medscape Medical News

source https://www.medscape.com/viewarticle/995265?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost